Results 71 to 80 of about 469 (114)

Levosimendan Pretreatment Attenuates Mesenteric Artery Ischemia/Reperfusion Injury and Multi-Organ Damage in Rats. [PDF]

Int J Mol Sci
Matković Z, Gajić Bojić M, Maličević U, Krivokuća A, Mandić-Kovačević N, Uletilović S, Amidžić L, Jovičić S, Barudžija M, Stojiljković MP, Gajanin R, Bolevich S, Škrbić R.   +12 more
europepmc   +1 more source

Evaluation of levosimendan as treatment option in a large case-series of preterm infants with cardiac dysfunction and pulmonary hypertension. [PDF]

Eur J Pediatr, 2023
Schroeder L, Holcher S, Leyens J, Geipel A, Strizek B, Dresbach T, Mueller A, Kipfmueller F.   +7 more
europepmc   +1 more source

Levosimendan: efficacy and safety in pediatric heart failure treatment. [PDF]

Rev Assoc Med Bras (1992)
Dündar MA, Yılmaz M, Argun M.
europepmc   +1 more source

Levosimendan improves the acute course of takotsubo syndrome: a pooled analysis. [PDF]

ESC Heart Fail, 2021
Jaguszewski MJ, Gasecka A, Hering D, Filipiak KJ, Szarpak L, Fijałkowski M, Gruchała M.   +6 more
europepmc   +1 more source

Levosimendan for postoperative subclinical heart failure after noncardiac surgery: a randomized, double-blinded, phase III trial. [PDF]

Nat Commun
Reiterer C, Kabon B, Taschner A, Graf A, Adamowitsch N, Horvath K, Emler D, Zotti O, Hantakova N, Hochreiter B, Fraunschiel M, Clement T, Fleischmann E.   +12 more
europepmc   +1 more source

Clinical efficacy and hemodynamic effects of levosimendan in cardiac surgery patients after surgery. [PDF]

J Cardiothorac Surg
Zhao M, Hou Y, Yuan M, Ma S, Yue Y.
europepmc   +1 more source

Levosimendan comes of age: twenty years in clinical use [PDF]

, 2020
Alvarez, J., Bettex, D., Bouchez, S., Fruhwald, S., Girardis, M., Guarracino, F., Heringlake, M., Herpain, A., Ricksten, S. E., Toller, W.   +9 more
core   +2 more sources

Effect of levosimendan on plasma intestinal barrier factors in heart failure patients with reduced ejection fraction. [PDF]

Zhong Nan Da Xue Xue Bao Yi Xue Ban
Wu Y, Hu X, Mao X, Liu H, Li S, Zeng Y, Xu P, Xiao H, Li D, Xia K.   +9 more
europepmc   +1 more source

Efficacy and safety of levosimendan in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: The LEVOCEST trial. [PDF]

Catheter Cardiovasc Interv
Bosa Ojeda F, Méndez Vargas C, Lacalzada Almeida J, Izquierdo Gómez MM, Jiménez Sosa A, Rodríguez Jiménez C, Sánchez-Grande Flecha A, Bosa Santana M, Yanes Bowden G.   +8 more
europepmc   +1 more source

Proarrhythmic changes in human cardiomyocytes during hypothermia by milrinone and isoprenaline, but not levosimendan: an experimental in vitro study. [PDF]

Scand J Trauma Resusc Emerg Med, 2023
Selli AL, Ghasemi M, Watters T, Burton F, Smith G, Dietrichs ES.   +5 more
europepmc   +1 more source